Immune Regulation of Disseminated Cancer Cell Dormancy

This proposal studies how dormant cancer cells that have disseminated to secondary organs avoid the immune response and how the immune system keeps them in check. Uncovering the involved mechanisms and preclinical evaluation of immunotherapies will reveal therapeutic opportunities for the minimal residual disease, which results in relapse of lethal metastatic diseases that account for the majority of patient deaths.